Summary

SASH1 encodes a modular scaffold protein characterised by an N-terminal sterile alpha motif (SAM) domain and a C-terminal Src homology 3 (SH3) domain. These domains orchestrate protein–protein interactions that govern cell adhesion, migration and survival. Under normal conditions, SASH1 contributes to tissue homeostasis by promoting apoptosis and stabilising cytoskeletal contacts. In cancer, SASH1 expression is frequently downregulated through mechanisms including promoter methylation and post-translational modification, leading to enhanced proliferation, invasion and therapeutic resistance. Transcriptional repression and epigenetic silencing of SASH1 have been documented in glioma and lung tumours, while proteolytic cleavage by caspases modulates its pro-apoptotic function. Restoring SASH1 levels or function has thus emerged as a promising approach to re-engage cell death pathways and curtail metastatic spread. The global significance of SASH1 spans multiple tumour types, and its modulation by small molecules offers potential for targeted intervention, enhancing sensitivity to conventional cytotoxics and improving patient prognosis.

Research from Nature Portfolio

Low SASH1 mRNA levels have been linked to poorer survival in non-small cell lung cancer. Experimental upregulation of SASH1 in lung adenocarcinoma cell lines reduced proliferation and increased sensitivity to cisplatin. Conversely, silencing SASH1 accelerated growth and chemoresistance. A small-molecule antihistamine was shown to elevate SASH1 protein and further sensitise cells to platinum-based therapy. These findings support SASH1 as both a prognostic indicator and a therapeutic target, suggesting that pharmacological induction of SASH1 could complement existing regimens in lung cancer management.

SASH1 Gene Regulation in Cancer Biology publication trend

The graph below shows the total number of articles in sash1 gene regulation in cancer biology across all publications each year (not limited to Nature Index journals).

Technical terms

Sterile alpha motif (SAM) domain: A protein-interaction module mediating oligomerisation and regulatory complex assembly.

Src homology 3 (SH3) domain: A small domain that recognises proline-rich motifs in partner proteins, facilitating signal transduction.

DNA methylation: Addition of methyl groups to cytosine residues in CpG islands, often resulting in transcriptional silencing.

Caspase-3: A cysteine protease central to execution of apoptosis, cleaving key substrates to drive cell death.

Scaffold protein: A non-enzymatic protein that organises signalling components into functional complexes.

References

  1. Activation and cleavage of SASH1 by caspase-3 mediates an apoptotic response. Cell Death & Disease (2016).
  2. SASH1 mediates sensitivity of breast cancer cells to chloropyramine and is associated with prognosis in breast cancer. Oncotarget (2016).
  3. Clinical Significance of SASH1 Expression in Glioma. Disease Markers (2015).
  4. HMGB1 contributes to SASH1 methylation to attenuate astrocyte adhesion. Cell Death & Disease (2019).
  5. SASH1 is a prognostic indicator and potential therapeutic target in non-small cell lung cancer. Scientific Reports (2020).

About these summaries

This Nature Research Intelligence Topic summary is created with the cited references and a large language model. We take care to ground generated text with facts, and have systems in place to gain human feedback on the overall quality of the process in line with our AI principles. We strive to create accurate and useful summaries for people unfamiliar with the research topic and that supports this goal. These pages are a beta release and will be updated as we learn how best to help people gain value from a research topic summary.

Nature Index 2026 Cancer

Cancer incidence is on the rise. Countries are meeting the challenge in different ways, such as through nationwide action plans and broadening early detection programmes. However, coordinating these efforts to make them accessible, targeted and effective is a balancing act. In this supplement, we explore the factors that are shaping these first lines of defence and the research efforts that are informing them.

Nature Index 2026 Cancer
Access for free
Nature Strategy Reports
Turn complex research questions into confident strategic decisions 

When you're under pressure to set direction, justify investment, or understand your competitive position, you need more than raw data — you need trusted insights you can act on.

  • Benchmark your performance against global peers using robust, methodologically sound analysis.

  • Combine quantitative metrics with qualitative expert insight to uncover strengths, gaps and emerging opportunities.

  • Gain tailored, decision-ready recommendations aligned to your strategic priorities.

Talk to us to learn more about our data dashboards and bespoke strategy reports.

Nature Masterclasses
Grow research skills, confidence and careers with training built for every stage of the research lifecycle.

Developed with Nature Portfolio journal Editors and internationally renowned experts. Discover three ways to learn:

  • Self-paced, online courses in convenient bite-sized units, covering key skills across scientific writing, publishing, grant writing, data analysis, and more.

  • Expert trainer-led workshops with hands-on exercises and real-time feedback across core research skills, delivered via interactive group sessions.

  • Editor-led workshops combining core principles in writing and publishing, personalised 1:1 feedback from Nature Portfolio Editors and hands-on exercises.

Explore course catalogues and workshop agendas, enquire about the options or request institutional pricing.